Phoenix A [98] were seeded (1.5–2 × 106 cells) in 10 cm dishes coated with 10 µg/mL rat tail collagen by incubating at 37 °C for 1–2 h. The next day these cells were transfected with TransIT-LT1 transfection reagent (cat # MIR 2306; Mirus Bio) in serum free medium according to manufacturer’s protocol. Transfected cells were then selected with puromycin at a concentration of 2 µg/mL. Once the cells reached 90% confluence, the medium was changed and left for 24 h at 32 °C for virus production. Viral supernatants were harvested for 3 rounds and spun down for 1 h at 4300 rpm at 4 °C, snap frozen in liquid nitrogen and stored at −80 °C.
The construct with hygromycin selection were transfected into Phoenix E and 72 h post-transfection the supernatant was used to transduce PT67 cells [99], which were selected with 300 µg/mL hygromycin, and the viral supernatant was harvested as described above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.